TickerStat.comwe like data

Retension Pharmaceuticals, Inc. (RTSN)

Price—Loading quote
RTSNNasdaq
Loading local price history

Financial charts

Revenue

No reported data

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Research & development$5.1M$1.3M
Operating income−$6.9M−$2.3M
Net income−$6.3M−$1.9M
Diluted EPSper diluted share-$7.83-$2.37
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Oct 1, 2024–Sep 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about RTSN yet. Start the conversation.

Write the first post